HIGHLIGHTSA Highlights Nifty showed negative trend on Friday. Nifty Future down 40.20 at 5725.00 This report contains the breakout of sell call we recommended on the basis of rising wedge and a new call for clients to take position in. Auro Pharma sell call we recommended hit both the targets in a single day. Investors’ kindly book full profit and take position in the fresh call provided below. Sell Karnataka bank future below 138.90 for targets 138/137 Past Performance: Auro Pharma sell call hit both targets on the same day of execution. Lupin almost hit 2 nd target. Bata India hit both targets Havells sell call hit both targets. R Power hit target same day of execution AP paper sell call hit both targets.
AURO PHARMA FUTURE- RISING WEDGE SELL BELOW 177.70 FOR TARGETS 175.20/172.70 SL 180.70 BUY ABOVE 250 FOR TARGETS OF 265/285 SL 235Auro Pharma sell call we recommended hit both thetargets.It made a low of 168.30 and our 2 nd target was 172.70Currently trading at 173.40Investors’ are advised to book full profitAuro Pharma was making rising wedge on hourly chartand we had written breakout below 178
KARNATAKA BANK FUTURE- RISING WEDGE SELL BELOW 138.90 FOR TARGETS 138/137 SL 140.90Sell KTK bank below 138.90KTK bank is making Rising wedge on hourly chartCurrently trading at 139.70Breakout will come below 139 and we expect rally tocontinue till 136A small stop loss is recommended at 140.90
DisclaimerThe information and view in this report, our website & all the service we provideare believed to be reliable, but we do not accept any responsibility (or liability) forerrors of fact or opinion. Users have the right to choose the product/s that suitsthem the most.Sincere efforts have been made to present the right investment perspective. Theinformation contained herein is based on analysis and up on sources that weconsider reliable.This material is for personal information and based upon it & takes noresponsibilityThe information given herein should be treated as only factor, while makinginvestment decision. The report does not provide individually tailor-madeinvestment advice. Epic research recommends that investors independentlyevaluate particular investments and strategies, and encourages investors to seekthe advice of a financial adviser. Epic research shall not be responsible for anytransaction conducted based on the information given in this report, which is inviolation of rules and regulations of NSE and BSE.The share price projections shown are not necessarily indicative of future priceperformance. The information herein, together with all estimates and forecasts, canchange without notice. Analyst or any person related to epic research might beholding positions in the stocks recommended. It is understood that anyone who isbrowsing through the site has done so at his free will and does not read any viewsexpressed as a recommendation for which either the site or its owners oranyone can be held responsible for . Any surfing and reading of the information isthe acceptance of this disclaimer.All Rights Reserved. Investment in equity & bullion market has its own risks.We, however, do not vouch for the accuracy or the completeness thereof. we are notresponsible for any loss incurred whatsoever for any financial profits or losswhich may arise from the recommendations above epic research does not purportto be an invitation or an offer to buy or sell any financial instrument. Our Clients(Paid Or Unpaid), Any third party or anyone else have no rights to forward orshare our calls or SMS or Report or Any other information provided by us to/withanyone which is related directly or indirectly with them. If found so, then SeriousLegal Actions can be taken.